Analyse Des Sillons Corticaux Par IRM morphométrique : développement de Biomarqueurs neurodéveloppementaux Des Troubles Bipolaires
The study, sponsored by Assistance Publique Hopitaux De Marseille, aims to develop neurodevelopmental biomarkers for bipolar disorder through morphometric MRI analysis of cortical sulci. This research addresses the phenotypic heterogeneity of bipolar disorder, potentially leading to improved patient stratification and targeted therapies. The market for bipolar disorder treatments is significant, with ongoing demand for innovative diagnostic and therapeutic solutions. The findings could enhance the understanding of bipolar disorder's neurodevelopmental aspects, positioning the sponsor favorably in the competitive landscape of psychiatric research. Diligence considerations include the study's ability to recruit participants effectively and the potential for collaboration with pharmaceutical companies interested in biomarker development.
Indication: Bipolar Disorder
Modality: RNA therapy
Target: GPR56 (sulcation marker) and neurodevelopmental biomarkers related to bipolar disorder.
Sponsor: Assistance Publique Hopitaux De Marseille
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 11, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: GPR56 (sulcation marker) and neurodevelopmental biomarkers related to bipolar disorder.
View original source fields
Condition raw: Bipolar Disorder
Condition normalized: Bipolar Disorder
Modality raw: RNA therapy
Modality normalized: RNA therapy
Target raw: GPR56 (sulcation marker) and neurodevelopmental biomarkers related to bipolar disorder.
Target normalized: GPR56 (sulcation marker) and neurodevelopmental biomarkers related to bipolar disorder.